Science Board meeting
Executive Summary
FDA's Science Board will wrap up its review of FDA's drug safety programs March 31; during a meeting in November, the agency outlined a restructuring of its drug safety operations (1"The Pink Sheet" Nov. 7, 2005, p. 3). The panel will also discuss a request from FDA to review the agency's science program. The meeting will be held at 5630 Fishers Lane in Rockville, Md. beginning at 8 a.m...